Sale of Emerald Performance Materials to American Securities Completed

Emerald Performance Materials announced that it has completed the sale of the company to an affiliate of private equity firm American Securities. Emerald has been an affiliated portfolio company of Sun Capital Partners since 2006.

Headquartered in Cuyahoga Falls, Ohio, Emerald's industry-leading brands serve a wide range of attractive end markets, including flavors and fragrances, food and beverage, personal and household care, composites, structural adhesives, coatings and plastics. The specialty chemical manufacturer's portfolio includes benzoic acid and derivatives such as fragrance ingredients and plasticizers, specialty resins, reactive liquid polymers and modifiers, antioxidants, accelerators, colorants, foam control products and other additives. Terms of the private transaction were not disclosed.

"We are excited about the completion of the sale of our company to American Securities and the opportunity to build upon the track record we have established," said Candy Wagner, president and chief financial officer of Emerald Performance Materials. "We are extremely proud of our accomplishments during our tenure as a Sun Capital Partners portfolio company - doubling the company's revenue and achieving a three-fold improvement in EBITDA. Emerald's employees are enthusiastic about the next step in our future and remain committed to continued innovation and growth of our company, while helping our customers and suppliers achieve their growth goals. We have many exciting opportunities ahead of us and look forward to this next phase as an affiliate of American Securities."

Emerald was formed in 2006 from the divesture of six specialty chemical businesses from Lubrizol and has since made four additional acquisitions in complementary businesses. Significant investments in new plant equipment have enabled the Company to expand capacity at its Rotterdam, Netherlands, and Kalama, Washington (U.S.) sites in order to meet increased customer demand for benzoic acid and down-stream specialty products such as non-phthalate plasticizers and fragrance ingredients. In addition, the company added assets at its Charlotte facility for expanded production of foam control and specialty silicone materials, increased capacity of its reactive modifiers at Maple Shade, New Jersey, and expanded R&D and pilot plant capabilities at Kalama, Cincinnati, Charlotte, Moorestown and Akron.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.